JAKARTA &ndash; PT Bank Mandiri (Persero) Tbk (BMRI) reported a 16.6% year-on-year increase in consolidated net profit in the first quarter of 2026, reaching IDR 15.4 trillion.
The performance was achieved despite a slight 1.8% decline in net interest income to IDR 25.05 trillion. Including income from its insurance business line, the figure fell further by 2.3% to IDR 25.3 trillion.
BMRI&rsquo;s net interest margin (NIM) stood at 4.7% in the first quarter of 2026, in line with the company&rsquo;s target range of 4.6&ndash;4.8%.
However, following the deconsolidation of PT Bank Syariah Indonesia (Persero) Tbk (BRIS) at the start of 2026, alongside various global challenges, BMRI revised down its 2026 NIM guidance to 4.5&ndash;4.7%.
Previously, IDNFinancials also reported a lower loan growth target for BMRI in 2026 following the divestment of BRIS, now set at 7&ndash;9%.
On a consolidated basis, BMRI&rsquo;s loan book appeared to contract 15.2% year-on-year to IDR 1.6 trillion. However, excluding BRIS loans in the first quarter of 2025, loan growth would have reached 16.2%.
Bank-only lending in the first quarter of 2026 still recorded solid growth of 17.4% to IDR 1.5 trillion, dominated by the corporate segment at IDR 800.6 billion.
Commercial loans stood at IDR 325.2 billion, followed by micro and payroll loans at IDR 197.8 billion, consumer loans at IDR 124.1 billion, and SME loans at IDR 82.6 billion.
On the funding side, consolidated third-party funds (excluding BRIS) grew 21% to IDR 1.7 trillion by the end of the first quarter of 2026, with a CASA ratio of 71.6%.
BMRI Corporate Banking Director M. Rizaldi said the company&rsquo;s loan expansion has been balanced with prudent asset quality management. Gross non-performing loans (NPL) stood at 0.98%, while net NPL was at 0.41%.
As of the end of the first quarter of 2026, BMRI recorded total assets of IDR 2,432 trillion and total equity of IDR 304.9 trillion. (ZH)

Loan growth reaches 16.2% post-BRIS deconsolidation, though NIM guidance for 2026 is lowered.